Qcdx
UEI: CXSKE19CDJH5
• CAGE: 81ZL7
Overview
Awardee Type
Parent
Federal Capability Statement
The QCDx mission is to develop a transcendent, world-best liquid biopsy for precision diagnosis of cancer by detection and deep characterization of Circulating Tumor Cells (CTCs) for improving clinical outcomes and the patient's quality of life. The company's Reveal Cell Heterogeneity technology aims to deliver on unmet needs for early cancer diagnosis, monitoring of treatment efficacy and surveillance for disease recurrence.
Keywords
Medical device, diagnostics, cancer, liquid biopsy, precision, CTC, live cell, drug efficacy testing
SBA Special Equipment
The proprietary RareScope provides sensitive detection of different CTC phenotypes with variable metastatic potential and isolates intact and live CTCs for further molecular analysis. It will also provide ex vivo evaluation of how cancer drugs affect live CTCs and surrounding White Blood Cells (WBCs), to aid in optimizing drug selection, before treatment is administered to the patient.
The RareScope processes fluorescently immunostained cell preparations using a fully automated and user friendly interface.
It is sold as a Research Use Only (RUO) medical device to cancer research institutions, pharmaceutical companies as diagnostic tool during drug development and to reference clinical laboratories for the development of Laboratory Developed Tests (LDTs).
Website
Headquarters
Rocky Hill, CT
United States
United States
Federal recipient
QCDX LLC
(UEI CXSKE19CDJH5, CAGE 81ZL7)
is headquartered in Rocky Hill CT.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The partnership
was founded in December 2016 and
federally registered in
February 2018.
Federal Registration and Certifications
Legal Name
QCDX LLC
UEI
CXSKE19CDJH5
CAGE Code
81ZL7
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 2, 2016
Initial Registration
Feb. 19, 2018
Last Registration
Dec. 18, 2024
Registration Activation
Dec. 18, 2024
Registration Expiration
Dec. 16, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
CT
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No